Table 2. Study outcome data.
| Baseline | 4-Weeks | 12-Weeks | |||||||
| Mean±SD | Median | Min-Max | Mean±SD | Median | Min-Max | Mean±SD | Median | Min-Max | |
| VAS | |||||||||
| Exercise only | 63.6±9.9 | 60 | 50-90 | 35.2±11.2 | 40 | 10-60 | 32.0±11.9 | 30 | 10-50 |
| Injection and exercise | 67.6±8.8 | 70 | 50-80 | 18.0±10.4 | 20 | 0-30 | 12.8±11.7 | 10 | 0-40 |
| NHP | |||||||||
| Exercise only | 224.8±115.0 | 205.2 | 62.5-480.2 | 141.5±81.3 | 103.3 | 25.0-331.9 | 140.5±81.2 | 112.4 | 25.0-323.0 |
| Injection and exercise | 278.8±128.8 | 270.2 | 75.0-523.8 | 112.8±88.5 | 101.9 | 0-330.5 | 97.9±91.7 | 87.2 | 0-355.5 |
| SD: Standard deviation; VAS: Visual Analog Scale; NHP: Nottingham health profile. | |||||||||